Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Infections Post Transplant

Nontuberculous mycobacterial infections in Chinese hematopoietic stem cell transplantation recipients

Summary:

Between 1995 and 2002, nine cases of nontuberculous mycobacterium (NTM) were isolated from 462 allogeneic stem cell transplant (SCT) recipients (1.9%), and none from 139 autologous cases. They included three cases each of Mycobacterium fortuitum and M. chelonae, and single cases of M. scrofalaceum, M. gordonnae and M. avium complex. Seven cases were respiratory, including five cases requiring treatment, and two involved infected catheters and vascular conduits. Compared with nine cases of mycobacterium tuberculosis (MTB) isolated in the same period, NTM isolation occurred later after HSCT and involved more unrelated donors. Important risk factors for NTM infection included significant aGVHD (P=0.043), leukemia relapse (P=0.022), MUD and mismatch SCT (P<0.001) and existence of BO (P<0.001). Coinfection with aspergillus was common. Invasive NTM disease required prolonged antimicrobial treatment in five cases due to M. fortuitum and M. chelonae. With better MTB prophylaxis, intensive immunosuppression and better awareness, NTM has become an emerging threat in oriental allogeneic HSCT recipients. The cutoff between colonization and infection, and the threshold for starting treatment is unclear. NTM isolation is a marker for severe immunosuppression and poor prognosis. When there is doubt over species identity or extent of infection, broad-spectrum cover may be prudent.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Patel R, Roberts GD, Keating MR, Paya CV . Infections due to nontuberculous mycobacteria in kidney, heart, and liver transplant recipients. Clin Infect Dis 1994; 19: 263–273.

    Article  CAS  PubMed  Google Scholar 

  2. Chan JC, So SY, Lam WK, Ip MS . High incidence of pulmonary tuberculosis in the non-HIV infected immunocompromised patients in Hong Kong. Chest 1989; 96: 835–839.

    Article  CAS  PubMed  Google Scholar 

  3. Yuen KY, Woo PC . Tuberculosis in blood and marrow transplant recipients. Hematol Oncol 2002; 20: 51–62.

    Article  CAS  PubMed  Google Scholar 

  4. Martino R, Martinez C, Brunet S et al. Tuberculosis in bone marrow transplant recipients: report of two cases and review of the literature. Bone Marrow Transplant 1996; 18: 809–812.

    CAS  PubMed  Google Scholar 

  5. Aljurf M, Gyger M, Alrajhi A et al. Mycobacterium tuberculosis infection in allogeneic bone marrow transplantation patients. Bone Marrow Transplant 1999; 24: 551–554.

    Article  CAS  PubMed  Google Scholar 

  6. Budak-Alpdogan T, Tangun Y, Kalayoglu-Besisik S et al. The frequency of tuberculosis in adult allogeneic stem cell transplant recipients in Turkey. Biol Blood Marrow Transplant 2000; 6: 370–374.

    Article  CAS  PubMed  Google Scholar 

  7. George B, Mathews V, Srivastava V et al. Tuberculosis among allogeneic bone marrow transplant recipients in India. Bone Marrow Transplant 2001; 27: 973–975.

    Article  CAS  PubMed  Google Scholar 

  8. Ozkaynak MF, Lenarsky C, Kohn D, Weinberg K, Parkman R . Mycobacterium avium-intracellulare infections after allogeneic bone marrow transplantation in children. Am J Pediatr Hematol Oncol 1990; 12: 220–224.

    Article  CAS  PubMed  Google Scholar 

  9. Mohite U, Das M, Saikia T et al. Mycobacterial pulmonary infection post allogeneic bone marrow transplantation. Leuk Lymphoma 2001; 40: 675–678.

    Article  CAS  PubMed  Google Scholar 

  10. Gaviria JM, Garcia PJ, Garrido SM et al. Nontuberculous mycobacterial infections in hematopoietic stem cell transplant recipients: characteristics of respiratory and catheter-related infections. Biol Blood Marrow Transplant 2000; 6: 361–369.

    Article  CAS  PubMed  Google Scholar 

  11. Kurzrock R, Zander A, Vellekoop L et al. Mycobacterial pulmonary infections after allogeneic bone marrow transplantation. Am J Med 1984; 77: 35–40.

    Article  CAS  PubMed  Google Scholar 

  12. Roy V, Weisdorf D . Mycobacterial infections following bone marrow transplantation: a 20 year retrospective review. Bone Marrow Transplant 1997; 19: 467–470.

    Article  CAS  PubMed  Google Scholar 

  13. Au WY, Lie AK, Ma SK et al. Allogeneic bone marrow transplantation for adult acute lymphoblastic leukemia: a single-centre experience. Hematol Oncol 1998; 16: 163–168.

    Article  CAS  PubMed  Google Scholar 

  14. Lee CK, Lie AK, Liang R et al. Outcome of Chinese patients with chronic myeloid leukaemia (CML) underwent allogeneic bone-marrow transplantation (BMT). Am J Hematol 1999; 61: 85–89.

    Article  CAS  PubMed  Google Scholar 

  15. Au WY, Lie AK, Kwong YL et al. Allogeneic bone marrow transplantation for severe aplastic anemia: the Hong Kong scenario. Hematol Oncol 1998; 16: 41–46.

    Article  CAS  PubMed  Google Scholar 

  16. Au WY, Chan AC, Lie AK et al. Recurrent isolated extramedullary relapses as granulocytic sarcomas following allogeneic bone marrow transplantation for acute myeloid leukemia. Bone Marrow Transplant 1998; 21: 205–208.

    Article  CAS  PubMed  Google Scholar 

  17. Ip MS, Yuen KY, Woo PC et al. Risk factors for pulmonary tuberculosis in bone marrow transplant recipients. Am J Respir Crit Care Med 1998; 158:1173–1177.

    Article  CAS  PubMed  Google Scholar 

  18. Leung AY, Suen CK, Lie AK et al. Quantification of polyoma BK viruria in hemorrhagic cystitis complicating bone marrow transplantation. Blood 2001; 98: 1971–1978.

    Article  CAS  PubMed  Google Scholar 

  19. Metchock BG, Nolte FS, Wallace RJJ . Mycobacterium. In: Murray PR, Baron EJ, Pfaller MA, Tenover FC, Yolken RH, (eds). Manual of Clinical Microbiology, 7th edn. American Society for Microbiology: Washington, DC, 1999.

    Google Scholar 

  20. Yam WC, Yuen KY, Seto WH . Direct detection of Mycobacterium tuberculosis in respiratory specimens using an automated DNA amplification assay and a single tube nested polymerase chain reaction (PCR). Clin Chem Lab Med 1998; 36: 597–599.

    Article  CAS  PubMed  Google Scholar 

  21. Annonymous. Diagnosis and treatment of disease caused by nontuberculous mycobacteria. This official statement of the American Thoracic Society was approved by the Board of Directors, March 1997. Medical Section of the American Lung Association. Am J Respir Crit Care Med 1997; 156(Part 2): S1–S25.

  22. Au WY, Fung A, Man C et al. Aberrant p15 gene promoter methylation in therapy-related myelodysplastic syndrome and acute myeloid leukaemia: clinicopathological and karyotypic associations. Br J Haematol 2003; 120: 1062–1065.

    Article  CAS  PubMed  Google Scholar 

  23. Annonymous. Notification and death rates of tuberculosis 1946–2001. Tropical Health Report, Deparment of Health, Hong Kong, 2002, vol. 2, pp 49–50.

  24. Hosker HS, Lam CW, Ng TK et al. The prevalence and clinical significance of pulmonary infection due to non-tuberculous mycobacteria in Hong Kong. Respir Med 1995; 89: 3–8.

    Article  CAS  PubMed  Google Scholar 

  25. Low K, Lee SS . The pattern of AIDS reporting and the implications on HIV surveillance. Public Health Epidemiol Bull, Hong Kong 2002; 11: 41–49.

    Google Scholar 

  26. Navari RM, Sullivan KM, Springmeyer SC et al. Mycobacterial infections in marrow transplant patients. Transplantation 1983; 36: 509–513.

    Article  CAS  PubMed  Google Scholar 

  27. Olivier KN, Yankaskas JR, Knowles MR . Nontuberculous mycobacterial pulmonary disease in cystic fibrosis. Semin Respir Infect 1996; 11: 272–284.

    CAS  PubMed  Google Scholar 

  28. Yuen KY, Chan KS, Chan CM et al. Use of PCR in routine diagnosis of treated and untreated pulmonary tuberculosis. J Clin Pathol 1993; 46: 318–322.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  29. Griffith DE . Risk–benefit assessment of therapies for Mycobacterium avium complex infections. Drug Saf 1999; 21: 137–152.

    Article  CAS  PubMed  Google Scholar 

  30. Peters EJ, Morice R . Miliary pulmonary infection caused by Mycobacterium terrae in an autologous bone marrow transplant patient. Chest 1991; 100: 1449–1450.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to W Y Au.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Au, W., Cheng, V., Ho, P. et al. Nontuberculous mycobacterial infections in Chinese hematopoietic stem cell transplantation recipients. Bone Marrow Transplant 32, 709–714 (2003). https://doi.org/10.1038/sj.bmt.1704210

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.bmt.1704210

Keywords

This article is cited by

Search

Quick links